Ampersand-owned ATS Labs acquires MTL assets

ATS Labs, which is owned by Ampersand Capital Partners, has bought the assets of Agawam, Mass.-based MicroTest Labs, a testing services provider for the medical device, pharmaceutical and biotech sectors. No financial terms were disclosed. The newly combined companies will soon be known as Accuratus Lab Services.

Square 1 Bank backs NutraMed

Square 1 Bank has provided a $12.5 million credit facility to NutraMed, a manufacturer of nutraceuticals and dietary supplements. Proceeds from the facility will be used in conjunction with an equity investment from Ampersand Capital Partners for acquisition financing and working capital.

Blue Sky BioServices Expands Executive Team

Blue Sky BioServices has appointed Edward Marple as president and CEO of Blue Sky BioServices. Blue Sky is majority owned by Ampersand Capital Partners, a healthcare-focused, middle market private equity firm.

Ampersand Capital Partners Adds Operating Partner

Healthcare-focused, middle market private equity firm Ampersand Capital Partners has appointed Cecil Kost as an operating partner. Kost will work with the Ampersand investment team to identify and evaluate new platform opportunities as well as assist on the existing portfolio.

Ampersand Expands Management Team

Ampersand Capital Partners, a healthcare-focused, middle market private equity firm, has made three appointments to its management team. Eric Lev has joined Ampersand as a partner, Dana Niles has joined Ampersand as the firm’s CFO and chief compliance officer and John Perkins has joined as an operating partner.

Lev, Niles Join Ampersand Capital

Ampersand Capital Partners said Monday that Eric Lev has joined as a partner, while Dana Niles was named CFO and Chief Compliance Officer. John Perkins also joined Ampersand as an operating partner. Lev was most recently at Water Street Healthcare Partners where he served on their investment team. Niles previously was CFO of HighPoint Capital. And Perkins was a senior executive at Talecris Biotherapeutics, an Ampersand portfolio company.

Ampersand Capital Acquires Willow Laboratories

Willow Laboratories, based in Lynn, Mass., has been acquired by Ampersand Capital Partners. Willow is a clinical and forensic toxicology laboratory that provides urine, hair, and saliva testing services to a wide range of healthcare providers, including treatment centers. Ampersand is a Boston-based, middle market private equity firm. Terms of the deal were not disclosed.

Ampersand Sells MedVenture Technology

Helix Medical has acquired MedVenture Technology Corp. Financial terms weren’t announced. The seller was Ampersand Capital Partners. MedVenture develops and manufactures minimally invasive surgical devices and catheter-based devices for medical device companies.

New PE-Backed Spinoff, Bioventus, Launches in Durham

Medical device company Smith & Nephew has launched a spinoff in Durham, N.C., called Bioventus. The company was formerly Smith & Nephew’s biologics division.Private equity firms Essex Woodlands, Pantheon Ventures, Spindletop Healthcare Capital, Alta Capital Partners, Ampersand Capital Partners, and White Pine Medical, are investing $118M to acquire 51% of Bioventus. PRESS RELEASE: Essex Woodlands […]

PEHUB Community

Join the 12500 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget